Latest Research

Plenty of research has linked regular exercise to a lower risk of cancer, but a new study suggests that getting into better shape could reduce the risk of prostate cancer in particular, a diagnosis that around 113 out of every 100,000 men get every year in the U.S.

Prostate Cancer Support Toronto Awareness Night Videos with experts in cancer research, psychology, and physiotherapists", Video,Learn Here,Treatment,Radiation Therapy,Sunnybrook Cancer Centre ,https://sunnybrook.ca/content/?page=prostate-cancer-brachytherapy%20,Prostate Brachytherapy: What to Expect,,"Brachytherapy involves the temporary placement of radioactive seeds into the prostate. This video explains what will happen you go through this treatment."

With the current PSA screening test has shown to be inaccurate, the preliminary findings of a new blood test show promise as a screening tool for prostate cancer. *Published February 2023

Researchers from Niagara Health have found that prostate cancer patients whose cancer returns after being treated with high-intensity focused ultrasound (HiFU) therapy can safely receive higher doses of radiation therapy. *Published October 2022

This Phase 3 clinical trial has shown significant improvements in metastasis-free survival for men with non-metastatic hormone (or castration) -sensitive prostate cancer and those at high risk for biochemical recurrence. *Published March 2023

A new screening method for prostate cancer is being trialled in British Columbia based on a blood test. *Published July 2022

Stay up to date with all the latest prostate cancer news using this webpage.

Typical prostate cancer screening tests distinguish between low-risk and high-risk cases; however, most patients fall in the middle. Researchers hope the current study will provide more in-depth information to guide health decisions for prostate cancer diagnosis. *Published May 2023

This recent study has taken a significant step in the right direction for prostate cancer screening! By examining the personalized genetic makeup of patients, researchers were able to determine gene variations in PSA levels unrelated to cancer, cutting down on unnecessary biopsies and improving the diagnosis of aggressive tumours. *Published June 2023

The Terry Fox Research Institute has embarked on a multi-pronged strategy to fund the country's best prostate cancer scientific teams and programs.

Multiparametric MRI is a promising diagnostic tool for prostate cancer that may reduce the need for biopsies to confirm the disease however, lesions can be difficult to detect. This study demonstrates the effectiveness of AI software at increasing the sensititvity for detection of prostate cancer. *Published May 2023

Bone biomarkers have previously been implicated in castration-resistant prostate cancer. This new study found that these biomarkers may also benefit the understanding of hormone-sensitive prostate cancer. Lower serum levels of these bone metabolism markers were associated with a lower mortality risk. *Published May 2023

This study examined the genetics of Hispanic men with prostate cancer and found they show important alterations in genes related to prostate cancer compared to non-Hispanic men. This is an essential step towards creating targeted therapies for individuals. *Published May 2023

PSMA-PET scans are gaining a foot hold in emerging technologies for the diagnosis of prostate cancer. For patients with high-risk localized prostate cancer this imaging technique may provide physicians with a better indication as to what treatment route to use. Listen to Dr.Ryan explain the benefits of PSMA-PET imaging. *Published May 2023

This database allows you to view recent trends in cancer prevalence. Searches can be filtered by cancer type for specific results however general overviews are available as well.

This resource provides current articles relevant to prostate cancer research and practices.

According to a study of Nova Scotian men, a new program to help cancer patients and survivors take charge of their physical and mental health after prostate cancer treatment has dramatically reduced psychological distress.

A new tool from the University of Alberta, in collaboration with UCLA, helps to reduce unnecessary prostate biopsies and target people based on the probable outcome of a biopsy. *Published February 2022

In a new study, the University of Ottawa's Interdisciplinary Centre for Black Health (ICBH) has discovered "large gaps in research" on how common types of cancer affect Black people in Canada. After conducting a meta-analysis of medical literature and the 20 most common types of cancer in Canada, the researchers behind the study found no data related to Black people. "What we found is … a real gap when we compared [cancer] research within Black communities and research within other communities," said Jude Mary Cénat, an associate professor at the university's School of psychology and ICBH director. *Published February 2023

This database provides the most up-to-date information on current clinical trials, including those actively recruiting. Filters can be set for cancer type, eligibility criteria, study type, phase, and location

New research has identified an enzyme involved in prostate cancer metabolism and the development of treatment resistance. Targetting this enzyme shows promise as a novel therapy for treatment-resistant prostate cancer. *Published February 2023

This publication provides the latest discovery for possible hypoxic prostate cancer treatment. Despite identifying genomic instability and hypoxia as risk factors, predicting and treating recurrence in intermediate-risk prostate cancer patients remains challenging. This underlies challenges in assigning the functional impact of these risk factors to mechanisms promoting prostate cancer progression. *Published April 2023